Carmen Bellas

Author PubWeight™ 25.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 2006 1.57
2 Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2002 1.44
3 Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol 2009 1.30
4 The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica 2006 1.21
5 Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009 1.15
6 Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol 2002 1.07
7 A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res 2009 1.05
8 Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 2004 1.04
9 Differential transplantability of human endothelial cells in colorectal cancer and renal cell carcinoma primary xenografts. Lab Invest 2008 0.98
10 Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Proc Natl Acad Sci U S A 2013 0.90
11 Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol 2004 0.88
12 Aberrant gene promoter methylation in plasma cell dyscrasias. Exp Mol Pathol 2008 0.87
13 Human papillomavirus genotype distribution in Madrid and correlation with cytological data. BMC Infect Dis 2011 0.85
14 The MHC-related protein 1 (MR1) is expressed by a subpopulation of CD38+, IgA+ cells in the human intestinal mucosa. Histol Histopathol 2009 0.84
15 Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature. Tumori 2003 0.84
16 Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study. Leuk Lymphoma 2010 0.83
17 Diagnostic value of JC/BK virus antibody immunohistochemistry staining in urine samples from posttransplant immunosuppressed patients in relation to polyomavirus reactivation. Acta Cytol 2008 0.82
18 RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies. Int J Oncol 2005 0.82
19 Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2010 0.81
20 Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients. Ann Otol Rhinol Laryngol 2002 0.81
21 Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin's disease. Clin Cancer Res 2008 0.80
22 Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients. Acta Otolaryngol 2003 0.80
23 Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features. Leuk Lymphoma 2008 0.80
24 Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection. Thyroid 2004 0.79
25 hMLH1 and MGMT inactivation as a mechanism of tumorigenesis in monoclonal gammopathies. Mod Pathol 2006 0.76
26 Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells. Mod Pathol 2011 0.76
27 Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications. Leuk Lymphoma 2011 0.76
28 Analysis of Epstein-Barr virus strains and variants in classical Hodgkin's lymphoma by laser microdissection. Histol Histopathol 2008 0.76
29 Epstein-Barr virus in the germinal centres of adenopathies affected by classic Hodgkin lymphoma. Histopathology 2011 0.75
30 Evidence of the intersection of Epstein-Barr virus with germinal center. APMIS 2011 0.75